Aruni Ghose

Aruni Ghose: Male Breast Cancer, A Single Institutional Clinicopathological Profiling

Aruni Ghose, Co-Founder and Chief Medical Officer of OncoFlow, shared an article by Shubha De Sarkar, et al. on LinkedIn:

“Hot Off the Press!

Thanks to the International Institute of Anticancer Research.

Professor Stergios Boussios and I collaborated with Dr. Soirindhri Banerjee and Dr. Shubha De Sarkar to help draft a Single Centre Real-World Clinicopathological Epidemiological Experience on a growing entity—Male Breast Cancer—from the Institute of Post Graduate Medical Education & Research SSKM Hospital.

Compared to existing literature, this Indian cohort had a significantly higher proportion of triple-negative breast cancer (TNBC). The most common presentation was at Stage 3, between ages 41 to 60, implying a younger cohort.

My association with the UKI Global Cancer Network and Cancer Health Disparities – London Global Cancer Week (LGCW) taught me that Global Oncology is bidirectional and that you cannot equalize inequalities if you never knew the inequalities.”

Male Breast Cancer: A Single Institutional Clinicopathological Profiling.

Authors: Shubha De Sarkar, et al.

Aruni Ghose: Male Breast Cancer, A Single Institutional Clinicopathological Profiling

More posts featuring Aruni Ghose.

Aruni Ghose Breast Cancer cancer Cancer Health Disparities Clinicopathological Profiling fight against cancer Global fight against cancer Institute of Post Graduate Medical Education & Research SSKM Hospital International Institute of Anticancer Research LGCW London Global Cancer Week OncoDaily OncoFlow Oncology Shubha De Sarkar Soirindhri Banerjee Stergios Boussios